Dr. Garg has answered the 53 most common questions patients ask about Stem Cell therapy. Topics include Understanding Stem Cell Therapy, Stem Cell Therapy for Specific Conditions, Cost, Insurance, and Value, Results, Recovery, and What to Expect & Stem Cell vs. Alternatives, Athletes, and Advanced Questions.
Stem cell therapy uses your own bone marrow aspirate (BMA) or microfragmented adipose tissue (MFAT) to deliver concentrated repair cells directly into damaged joints, tendons, and ligaments.
These cells, called mesenchymal signaling cells (MSCs), release anti-inflammatory proteins, recruit your body’s repair mechanisms, and create an environment that supports new tissue formation. Unlike synthetic drugs that mask symptoms, this targets the underlying structural damage.
Our Dynamic Stem Cell+ protocol selects BMA or MFAT based on your specific pathology, because different tissue types respond better to different biologic sources. Every injection is ultrasound-guided.
Most patients begin noticing improvement within the first few months.
Patient Experience: One patient with full-thickness rotator cuff tears in both shoulders received shockwave, PRP, and MFAT over two months and plays ice hockey three times a week at age 65, a year and a half later.
BMA draws regenerative cells from your hip bone, while MFAT harvests them from a small sample of your own fat tissue. Both are autologous and performed same-day.
BMA is rich in mesenchymal signaling cells and hematopoietic growth factors, making it effective for bone and cartilage conditions. MFAT provides a scaffold of regenerative cells within an adipose matrix that suits soft tissue and tendon applications.
We select BMA or MFAT based on your diagnosis through our Dynamic Stem Cell+ protocol. This is a clinical decision, not a one-size-fits-all approach.
Choosing the right biologic source directly impacts your outcome.
Patient Experience: Most patients appreciate that their treatment is matched to their specific condition rather than defaulting to whatever the clinic has on the shelf.
There are currently no FDA-approved stem cell therapies for musculoskeletal conditions. However, using your own BMA or MFAT falls within FDA guidelines for same-day autologous procedures when tissue is minimally manipulated and used homologously.
We are not using lab-cultured cells, donor cells, or synthetic products. Your own tissue is harvested, processed at the point of care, and reinjected the same day. Many clinics cannot say this because they rely on off-the-shelf products that fall outside this framework.
Our Dynamic Stem Cell+ protocol strictly follows FDA guidelines for autologous biologic procedures using only your own cells.
Understanding what is and is not compliant protects you from clinics cutting corners.
Patient Experience: Patients consistently tell us the regulatory transparency gave them confidence before committing to treatment.
Stem cell therapy for musculoskeletal conditions has a growing body of clinical evidence supporting its effectiveness, particularly for knee osteoarthritis, tendon injuries, and cartilage damage. It is not purely experimental.
Published studies show improvement rates from 60 to 92 percent depending on the condition, the biologic source, and the procedure quality. The evidence base continues expanding as randomized controlled trials and long-term data mature.
Our Dynamic Stem Cell+ protocol uses evidence-based biologic selection combined with ultrasound-guided delivery to produce consistent, measurable outcomes.
Over 90% of our patients self-report a 75% or greater improvement following treatment.
Patient Experience: Most patients who were initially uncertain about stem cell therapy report being glad they moved forward.
Autologous stem cell injections using your own BMA or MFAT have an excellent safety profile because the cells come from your own body, eliminating rejection or allergic reaction risk.
The most common side effects are temporary soreness at the harvest and injection sites, mild swelling, and bruising. Serious complications are extremely rare when performed by a trained physician using sterile technique and image guidance.
At Dynamic Athlete, every harvest and injection in our Dynamic Stem Cell+ protocol is physician-performed under real-time ultrasound. We don’t hand any part of this off to a tech or PA.
Safety is built into every stage.
Patient Experience: Most patients experience only mild, temporary soreness with no significant adverse effects.
The biologic source directly affects the types of repair cells, growth factors, and scaffolding delivered to the damaged tissue. Bone marrow and adipose each provide different cellular advantages.
BMA is effective for bone, cartilage, and intra-articular conditions. MFAT provides an intact extracellular matrix with embedded regenerative cells suited for tendon repair. Selecting the wrong source for the wrong condition leads to suboptimal results.
We match the biologic source to the pathology through our Dynamic Stem Cell+ protocol. This decision is based on your imaging, your diagnosis, and the tissue being treated.
The source matters because the biology is different.
Patient Experience: I’ve seen patients who got the wrong biologic elsewhere come to us wondering why nothing worked. The answer was usually this simple.
Look for a provider who performs a thorough diagnostic workup, uses image-guided injections, offers more than one biologic source, and can explain why they are recommending a specific treatment.
Many clinics offer only one type of stem cell product, perform blind injections without ultrasound, or use donor-derived products containing no viable living cells. These approaches significantly reduce the likelihood of meaningful results.
Our Dynamic Stem Cell+ protocol uses autologous BMA or MFAT selected by pathology, ultrasound-guided delivery, and a plan that may include Dynamic Shockwave+ to prime the tissue before injection.
The quality of the provider determines the quality of the outcome.
Patient Experience: Most patients choose Dynamic Athlete after comparing clinical depth across multiple consultations.
Amniotic and umbilical cord products marketed as stem cell treatments typically contain no viable living stem cells. Independent lab analyses have consistently shown these products lack the regenerative cells needed for meaningful tissue repair.
These products are heavily marketed because they are easy to administer and require no harvesting. When patients pay for them and see poor results, it damages confidence in legitimate regenerative medicine.
We use only autologous cells from your own bone marrow or adipose tissue in our Dynamic Stem Cell+ protocol, which contain verified living regenerative cells.
Not all stem cell treatments are equal. The source determines whether you receive actual regenerative biology.
Patient Experience: Many patients who failed amniotic or cord blood treatments see real improvement after switching to autologous therapy.
Yes. Combining stem cell therapy with PRP and shockwave can enhance outcomes by priming tissue before injection and extending the regenerative signal after treatment.
Focused shockwave stimulates neovascularization and activates dormant repair cells, creating a more receptive environment. PRP adds concentrated growth factors that support the signaling pathways stem cells use to drive tissue repair. When combined strategically, each modality amplifies the others.
Our Dynamic Stem Cell+ protocol is often combined with Dynamic PRP+ and Dynamic Shockwave+ as part of a comprehensive regenerative plan. Having all modalities under one roof allows treatment plans no single-service clinic can replicate.
The combination approach consistently produces the strongest and most sustained improvement.
Patient Experience: Patients treated with all three modalities report noticeably better outcomes than single-treatment approaches.
Your stem cell therapy appointment at Dynamic Athlete is a same-day outpatient procedure including evaluation, tissue harvesting, point-of-care processing, and ultrasound-guided injection.
For BMA, bone marrow is drawn from the posterior iliac crest under local anesthesia. For MFAT, adipose tissue is harvested through minimally invasive lipoaspiration. Both are processed at the point of care and injected same-day.
Our Dynamic Stem Cell+ protocol includes pre-treatment tissue priming with Dynamic Shockwave+ when indicated, and every injection is placed under real-time ultrasound guidance. The entire process takes two to three hours.
There are no surprises. We walk you through every step.
Patient Experience: Most patients describe the appointment as more straightforward than they anticipated.
Stem cell therapy can reduce pain, improve function, and support cartilage health in patients with knee arthritis, particularly those wanting to avoid or delay knee replacement.
BMA delivers mesenchymal signaling cells into the joint where they reduce catabolic enzymes, support chondrocyte survival, and create an environment favoring tissue preservation over continued degeneration. Published studies show significant improvement in pain and function at one and two year follow-ups.
Our Dynamic Stem Cell+ protocol for knee arthritis uses BMA with ultrasound-guided intra-articular injection to maximize biologic delivery into the joint space.
Many patients maintain improved function for years after treatment.
Patient Experience: One patient with degeneration in both knees chose MFAT, PRP, and HA as her long-term protocol to avoid surgery and continue running and hiking pain-free.
Stem cell therapy has helped many patients avoid or significantly delay knee replacement by reducing pain, improving function, and slowing the degenerative process.
Knee replacement is major surgery with months of recovery, potential complications, limited implant lifespan, and permanent alteration of your anatomy. For patients with remaining cartilage, stem cell therapy can extend the functional life of the joint.
Our Dynamic Stem Cell+ protocol targets patients who want to preserve their natural joint, using BMA with ultrasound guidance to deliver regenerative cells precisely where needed.
Surgery is irreversible. Exploring stem cell therapy first preserves your options.
Patient Experience: One patient told she needed a full knee replacement had stem cell and PRP at Dynamic Athlete instead. She is now pain-free, climbing, and ready for ski season. Surgery on her knee would not have solved the problem.
Both hip arthritis and hip labral tears respond well to stem cell therapy, which delivers regenerative cells directly into the damaged joint structures.
Hip arthritis involves progressive cartilage loss and chronic inflammation. Labral tears involve damage to the fibrocartilage ring cushioning the hip socket. Both conditions respond to anti-inflammatory and regenerative effects of mesenchymal signaling cells from BMA.
We always perform hip injections under ultrasound guidance through our Dynamic Stem Cell+ protocol because the hip joint is deep and blind injections frequently miss the capsule. Accurate placement is essential.
Many patients regain the ability to walk, hike, and cycle comfortably.
Patient Experience: Most patients with hip conditions experience improved mobility and reduced pain within a few months.
Stem cell therapy can promote healing in rotator cuff tears, shoulder arthritis, and labral injuries by delivering concentrated regenerative cells directly into the damaged structures.
Partial rotator cuff tears involve disrupted tendon fibers the body struggles to repair due to limited blood supply. BMA or MFAT delivers signaling cells and growth factors that stimulate collagen production and tendon remodeling at the cellular level.
Our Dynamic Stem Cell+ protocol selects the biologic source best matched to whether it is a tendon tear, cartilage defect, or labral injury. Every shoulder injection is ultrasound-guided.
Many patients avoid surgery and return to full function.
Patient Experience: One patient waited a year and a half to post his review to make sure his shoulders were healed and not just a temporary fix. At 65, he plays hockey three times a week.
Chronic Achilles tendinopathy, partial tears, and post-surgical repair all respond to stem cell therapy, which delivers regenerative cells that promote tendon remodeling.
Achilles injuries are common in runners training on Colorado’s Front Range trails. Chronic tendinopathy involves collagen disorganization and failed healing responses. MFAT provides an adipose scaffold with embedded regenerative cells particularly suited for tendon repair.
Our Dynamic Stem Cell+ protocol uses MFAT or BMA based on severity and nature of the tendon damage, injected under ultrasound guidance directly into the affected region.
Most athletes return to training within a structured rehabilitation timeline.
Patient Experience: I see a lot of runners who thought their trail days were over come back stronger than expected.
Stem cell therapy can support healing in certain meniscus tears, particularly degenerative tears and tears in the vascular zone, potentially avoiding arthroscopic surgery.
The meniscus has limited blood supply in its inner zone, which is why many tears don’t heal on their own. BMA provides concentrated signaling cells and growth factors that enhance the repair response. For degenerative tears with arthritis, stem cell therapy also addresses the inflammatory joint environment.
Our Dynamic Stem Cell+ protocol uses ultrasound-guided delivery to place the biologic precisely at the tear location within the joint.
Many patients avoid arthroscopy with this approach.
Patient Experience: Most patients with meniscus tears find the healing support they need without going under the knife.
Stem cell therapy can be effective for certain causes of chronic low back pain, particularly SI joint instability and facet arthropathy, two of the most underdiagnosed pain generators in the spine.
If your MRI looks fine but your back still hurts every day, your SI joint may be the problem nobody checked. Damaged SI ligaments allow excessive motion and chronic inflammation. BMA delivers regenerative cells directly into the ligaments, promoting collagen repair and stabilization.
Our Dynamic Stem Cell+ protocol starts with thorough diagnostics to find the true pain generator. We often combine treatment with Dynamic Mind+ (EXOMIND) and Dynamic Core+ (EMSELLA) to address the full picture.
Treating the right structure is the first step to getting better.
Patient Experience: Patients who failed years of epidurals and facet blocks improve significantly once the SI joint is properly treated.
Yes. BMA or MFAT can strengthen damaged SI joint ligaments by delivering regenerative cells that promote collagen repair and improve joint stability.
SI joint instability is one of the most underdiagnosed causes of chronic low back pain. If you’ve bounced between specialists and been told nothing is structurally wrong, this is likely the structure nobody evaluated. Damaged posterior ligaments allow excessive motion, creating pain radiating into the back, buttock, and sometimes the leg.
Our Dynamic Stem Cell+ protocol uses ultrasound-guided injection into the posterior SI ligaments, often combined with Dynamic Shockwave+ to prime the tissue and Dynamic Core+ (EMSELLA) to reinforce stability gains.
Identifying the SI joint changes the trajectory for chronic pain patients who’ve been searching for answers.
Patient Experience: One patient was advised she needed a knee replacement. Dr. Garg identified the actual source at her SI joint, treated with stem cell and PRP, and now she is pain-free, climbing, and ready for ski season.
Stem cell therapy can support cartilage repair and ligament healing in the ankle for patients with osteochondral defects, chronic instability, or post-traumatic arthritis.
Ankle cartilage defects have limited natural healing capacity. BMA delivers regenerative cells directly into the defect site, supporting new cartilage formation and reducing inflammation that accelerates deterioration. For ligament injuries, MFAT provides a scaffold supporting structural repair.
Our Dynamic Stem Cell+ protocol matches the biologic source to the tissue being treated, with ultrasound-guided placement for precision.
Many patients return to hiking, running, and skiing with improved ankle function.
Patient Experience: I work with a lot of trail runners who thought ankle surgery was their only option. Most of them are back out there.
For chronic tendon injuries that have failed rest, physical therapy, and cortisone, stem cell therapy is particularly effective because it delivers regenerative cells that restart the stalled repair process.
Chronic tendinopathy involves degenerative changes where normal collagen has been replaced by disorganized tissue that cannot withstand load. MFAT provides an adipose matrix with embedded signaling cells effective for tendon applications, while BMA delivers concentrated growth factors stimulating collagen remodeling.
We select BMA or MFAT based on the specific tendon and degree of degeneration through our Dynamic Stem Cell+ protocol, delivered under ultrasound guidance.
Tendons that stop healing on their own often respond when given the right biological stimulus.
Patient Experience: Many patients with chronic tendon problems that failed everything else see meaningful improvement.
Stem cell therapy supports cartilage preservation and repair by delivering regenerative cells that reduce breakdown, support chondrocyte function, and improve the overall joint environment.
Cartilage lacks blood supply and has very limited regenerative capacity. BMA delivers mesenchymal signaling cells that reduce the catabolic enzymes responsible for cartilage destruction. While complete regeneration is not guaranteed, slowing degeneration and improving existing cartilage quality produces real functional improvement.
Our Dynamic Stem Cell+ protocol uses high-quality BMA with ultrasound-guided placement directly into the affected knee compartment.
Preserving cartilage today extends the life of your joint for years to come.
Patient Experience: Patients with knee cartilage damage consistently notice improved comfort and function within a few months of treatment.
Even in advanced arthritis, stem cell therapy can provide meaningful pain relief and improved function, though expectations should be calibrated to joint damage severity.
In bone-on-bone conditions, cartilage is severely depleted. Stem cells will not regrow what is completely gone. However, BMA can reduce the chronic inflammatory cascade, improve remaining cartilage and synovial tissue, and slow further degeneration. Many patients maintain activity and delay replacement.
Our Dynamic Stem Cell+ protocol uses high-quality BMA with precise ultrasound-guided delivery. For patients with chronic pain affecting sleep and stress, Dynamic Mind+ (EXOMIND) can optimize the nervous system for healing.
Even in advanced cases, meaningful improvement is possible.
Patient Experience: Most patients with severe arthritis who try stem cells before committing to surgery are glad they explored the option.
Stem cell therapy is used by athletes at every level for tendon tears, cartilage damage, ligament sprains, and joint degeneration from years of high-demand activity.
Athletes need to return to full performance, not just daily function. Stem cell therapy supports structural tissue repair at the cellular level, meaning the healed tissue is stronger and more resilient than scar tissue from natural healing alone.
Our Dynamic Stem Cell+ protocol is designed for patients whose goal is returning to sport. We build return-to-activity protocols around each patient’s athletic demands.
Your goal is not just to feel better. It is to perform again.
Patient Experience: Many Front Range athletes return to running, cycling, skiing, and climbing at their previous level after treatment.
BMA can be considered for certain cases of degenerative disc disease, particularly when the disc is a confirmed pain generator and the patient wants to avoid spinal surgery.
Disc degeneration involves loss of hydration, structural integrity, and height. BMA delivers regenerative cells that may support disc cell survival and reduce inflammatory pain. However, outcomes for disc conditions are more variable than for peripheral joints and tendons.
Our Dynamic Stem Cell+ protocol focuses primarily on joints and tendons where evidence is strongest. When disc pathology is present, we evaluate whether the disc is truly the pain generator before recommending treatment.
Accurate diagnosis determines whether stem cell therapy is the right approach for your spine.
Patient Experience: Patients with confirmed discogenic pain often see improvement, though results vary more than with peripheral joints.
Hip labral tears and FAI both respond to stem cell therapy, which delivers regenerative cells into the damaged labrum and joint structures.
The hip labrum deepens the socket and distributes load. When torn, it causes clicking, catching, and deep hip pain. BMA delivers signaling cells that support labral repair and reduce inflammation inside the joint.
Our Dynamic Stem Cell+ protocol uses ultrasound-guided delivery to ensure the biologic reaches the labrum and capsule rather than depositing outside the joint. Accurate placement separates effective treatment from wasted biology.
Many patients return to full activity without surgical repair.
Patient Experience: Patients with labral tears and FAI regularly report significant improvement in hip function within a few months.
The cost of stem cell therapy varies based on the condition, biologic source (BMA or MFAT), and procedure complexity. We provide transparent pricing during your consultation.
Stem cell therapy requires tissue harvesting, point-of-care processing, and image-guided injection. The investment reflects the clinical expertise, biologic quality, and imaging technology required to execute the procedure at the highest level.
Our Dynamic Stem Cell+ pricing is discussed during evaluation with clear information about what is included and why. No hidden fees, no surprise charges.
The value is best measured against the total cost of surgery, months of rehab, time off work, and the quality of life you recover.
Patient Experience: Most patients find stem cell therapy is a fraction of the total cost of surgical intervention when everything is factored in.
Most insurance plans do not cover stem cell therapy for musculoskeletal conditions. Insurance carriers classify these procedures as investigational despite growing clinical evidence.
This classification reflects reimbursement policy, not science. The evidence continues to grow, but coverage has not kept pace. This is similar to how PRP was treated for years before the evidence became impossible to ignore.
We accept HSA and FSA payments for our Dynamic Stem Cell+ protocol and provide all documentation needed for your accounts. Transparent pricing with no hidden fees.
The question is not whether it works. It is whether your insurance recognizes the science yet.
Patient Experience: Most patients who invest out of pocket view it as one of the best decisions they have made for their long-term health.
Yes. Stem cell therapy is a qualified medical expense under most HSA and FSA plans because it is performed by a licensed physician for a diagnosed medical condition.
Using pre-tax dollars can represent meaningful savings on your investment. This is particularly beneficial for patients on high-deductible health plans unlikely to reach their deductible through insurance-covered treatments alone.
We process HSA and FSA payments for our Dynamic Stem Cell+ protocol and provide all necessary documentation. Unlike clinics that just take your card, we structure the paperwork so your accounts stay clean with your plan administrator.
Pre-tax dollars make the investment in regenerative treatment more accessible.
Patient Experience: Many patients use HSA or FSA funds and appreciate the financial flexibility it provides.
For many patients, stem cell therapy costs significantly less than surgery when you factor in the procedure, anesthesia, hospital fees, rehabilitation, time off work, and months of recovery.
A knee replacement can cost tens of thousands of dollars or more with insurance, and the recovery typically means four to six months before returning to full activity. Stem cell therapy is same-day with minimal downtime and no surgical risk.
Our Dynamic Stem Cell+ protocol is designed to help patients avoid or delay surgery, saving money, time, and quality of life.
What is your time worth? What would you pay to get back months of your life?
Patient Experience: One professional skier and mountain biker described being lightyears ahead of where she was and wishes she had found Dynamic Athlete before her surgeries.
Stem cell therapy involves harvesting tissue, specialized point-of-care processing, and a more complex clinical protocol that takes two to three hours. PRP requires a blood draw and centrifuge, which is straightforward by comparison.
Stem cell therapy requires bone marrow aspiration or lipoaspiration, specialized processing equipment, and additional physician time. The biologic itself delivers a broader range of regenerative cells and growth factors than PRP alone.
Our Dynamic Stem Cell+ protocol represents a higher level of biologic intervention for conditions where Dynamic PRP+ alone may not provide sufficient repair stimulus.
The right biologic for the right condition at the right time produces the best return on investment.
Patient Experience: Most patients understand the additional value when their condition requires a stronger regenerative approach.
The choice depends on your condition severity, tissue involved, imaging findings, and response to previous treatments. This is a clinical decision made during evaluation.
PRP is typically appropriate for mild to moderate tendon injuries, early arthritis, and ligament damage. Stem cell therapy suits more advanced degeneration, larger tissue defects, and cases where PRP was insufficient.
We offer both Dynamic PRP+ and Dynamic Stem Cell+ so your recommendation is based on your specific diagnosis, not a preset protocol. This is what separates a clinical decision from a sales pitch.
Getting the right treatment matters more than choosing the most expensive option.
Patient Experience: Most patients appreciate having both available so treatment matches their exact situation.
Most patients begin noticing improvement within two to three months, with continued gains over six to twelve months as the regenerative process progresses.
Stem cell therapy initiates a biological repair cascade that takes time. The early weeks involve cell signaling and inflammation modulation. The following months involve new collagen production, cartilage support, and tissue remodeling. For patients with chronic pain, we sometimes recommend Dynamic Mind+ TMS therapy (EXOMIND) to optimize the nervous system so it supports rather than suppresses the healing response.
Our Dynamic Stem Cell+ protocol uses high-quality biologic preparation and ultrasound-guided placement to give the process the strongest possible start.
The timeline requires patience, but the results are structural and lasting.
Patient Experience: Most patients report steady, progressive improvement rather than immediate relief.
Results can last two to five years or longer depending on the condition, damage severity, and how the patient manages activity and joint health afterward.
Because stem cell therapy promotes structural repair rather than masking symptoms, improvements are durable. Cartilage that is preserved, tendons remodeled, and ligaments strengthened maintain their improved state. For progressive conditions like osteoarthritis, periodic maintenance treatments may extend benefit further.
We monitor progress after Dynamic Stem Cell+ treatment and adjust your long-term joint care plan based on clinical response and imaging.
The goal is lasting structural improvement, not temporary relief.
Patient Experience: Many patients enjoy years of sustained benefit with improved function and reduced pain that persists well beyond the treatment date.
Most patients return to daily activities within a few days, with gradual return to exercise over four to eight weeks depending on the tissue treated.
You may experience soreness at the harvest site and injection site for the first few days. This is normal and manageable. Activity restrictions are specific to the condition and tissue that received the biologic.
After Dynamic Stem Cell+ treatment, you receive a detailed recovery and rehabilitation protocol built around your condition, activity level, and goals. We don’t hand you a generic sheet, the protocol is specific to getting you back to your activities.
Most patients do not need extended time off work.
Patient Experience: Recovery is far easier than most patients expect, especially compared to surgical alternatives.
Your appointment typically takes two to three hours and includes clinical evaluation, tissue harvesting, point-of-care processing, and ultrasound-guided injection.
We begin with imaging review and focused physical examination. The tissue harvest is performed under local anesthesia. While your biologic is processed, you rest comfortably. The injection is then performed under real-time ultrasound guidance.
You leave same-day with clear post-procedure instructions, activity guidelines, and a follow-up plan specific to your condition. Our Dynamic Stem Cell+ protocol is designed so you know exactly what happens at every stage.
You will never be left guessing what comes next.
Patient Experience: Most patients describe the experience as straightforward and more comfortable than they anticipated.
Most patients describe it as a pressure sensation with brief discomfort, not sharp pain. The area is thoroughly numbed with local anesthesia before we begin.
The aspiration is performed from the posterior iliac crest, which is rich in regenerative cells and accessible with minimal discomfort. The actual draw takes only a few minutes. Some patients feel a deep aching pressure that resolves quickly.
We use techniques refined through extensive experience to minimize discomfort during the BMA harvest for our Dynamic Stem Cell+ protocol.
The brief discomfort is manageable for the vast majority of patients.
Patient Experience: Almost everyone says afterward that it was far less painful than they feared. The anticipation is worse than the procedure.
Temporary soreness at the harvest and injection sites is the most commonly reported side effect, along with mild swelling and bruising that resolves within a few days. Serious adverse events are extremely rare.
Because the cells come from your own body, there is no risk of allergic reaction, rejection, or disease transmission. The harvest site may be sore for a few days. The injection site may feel swollen or stiff as the inflammatory healing response activates.
Our Dynamic Stem Cell+ protocol uses strict sterile technique and ultrasound-guided injection to minimize procedural risk. Every step is physician-performed.
Stem cell therapy has an excellent safety profile when performed by an experienced physician.
Patient Experience: Most patients report only mild, temporary soreness with no significant side effects.
Most patients require one treatment, with the possibility of a second if the condition is complex or the initial response suggests additional biologic support would be beneficial.
Unlike PRP, which may be performed as a series, stem cell therapy delivers a more potent regenerative stimulus in a single procedure. Some patients with advanced or multi-joint conditions may benefit from a second treatment six to twelve months later based on clinical progress.
We evaluate your response before recommending anything additional through our Dynamic Stem Cell+ protocol. We do not prescribe repeat procedures unless the evidence supports it.
One well-executed treatment is better than multiple mediocre ones.
Patient Experience: Most patients achieve meaningful improvement from a single treatment session.
You can return to light activity within a few days and gradually progress to full exercise over four to eight weeks, depending on the tissue treated and your sport’s demands.
Protecting the treated tissue during the early regenerative phase is critical. Returning to high-impact activity too soon can disrupt the repair process. We provide a structured, progressive return-to-activity protocol that keeps you moving while protecting the biologic investment.
After Dynamic Stem Cell+ treatment, your rehabilitation and return-to-sport timeline is built around your specific condition and athletic goals.
Getting you back to full activity safely is the entire purpose of treatment.
Patient Experience: Most athletes return to running, cycling, skiing, or climbing within their structured timeline.
The key factors are biologic preparation quality, injection accuracy, condition severity, overall health, and the state of your nervous system.
Patients with chronic pain often have sympathetic dominance, an overactive stress response that suppresses healing mechanisms. Sleep, nutrition, and stress directly influence how effectively tissue responds to regenerative treatment.
We address these comprehensively. Beyond our Dynamic Stem Cell+ protocol, patients with chronic pain and elevated stress can benefit from Dynamic Mind+ TMS therapy (EXOMIND), which resets the nervous system toward a parasympathetic state that supports healing.
Healing is not just about the cells. It is about creating the conditions for those cells to work.
Patient Experience: Patients who optimize their overall health alongside treatment consistently experience the best outcomes.
PRP uses concentrated platelets and growth factors from your blood to stimulate repair. Stem cell therapy uses mesenchymal signaling cells from BMA or MFAT to deliver a broader and more potent regenerative stimulus.
PRP amplifies healing signals. Stem cells provide the cellular machinery for tissue repair along with growth factors, cytokines, and extracellular matrix components. Stem cell therapy is generally appropriate for more advanced conditions, larger defects, and cases where PRP was insufficient.
We offer both Dynamic PRP+ and Dynamic Stem Cell+ so the recommendation is based on your specific condition, not a one-size protocol.
The right biologic at the right stage produces the best outcome.
Patient Experience: Most patients value having both options available so treatment matches their specific needs.
Stem cell therapy is appropriate for patients with remaining cartilage who want to preserve their natural joint. Knee replacement is appropriate when the joint is severely destroyed and conservative options are exhausted.
The decision depends on arthritis severity, activity goals, age, and how much functional surface remains. Imaging and clinical evaluation determine which approach gives you the best chance of returning to the life you want.
We use Dynamic Stem Cell+ to help patients preserve their natural joints as long as possible. When evidence suggests stem cell therapy can improve function and delay surgery, we recommend it.
Trying stem cells first preserves your options. Surgery is a one-way door.
Patient Experience: Many patients recommended for knee replacement found enough improvement to maintain activity without surgery.
Stem cell therapy supports tissue repair and joint preservation, while cortisone only provides temporary inflammation relief and can accelerate degeneration with repeated use.
Cortisone suppresses pain quickly but does nothing to address structural damage. Multiple studies show repeated cortisone injections are associated with accelerated cartilage loss, tendon weakening, and worse long-term outcomes. Stem cell therapy works in the opposite direction.
Our Dynamic Stem Cell+ protocol is designed for patients who want to protect their joints long-term rather than trade short-term relief for accelerated breakdown.
Short-term masking that damages your joint is not a treatment strategy.
Patient Experience: Most patients who transition from cortisone to stem cells experience more sustained improvement and feel better about their trajectory.
Most clinics offer only one biologic source because they lack the training, equipment, or expertise to harvest and process multiple tissue types.
Some only offer BMA. Others only MFAT. Still others rely on amniotic or cord blood products with no viable cells. A single-source approach means every patient gets the same treatment regardless of whether a different biologic would work better.
Our Dynamic Stem Cell+ protocol offers both BMA and MFAT, selected based on diagnosis, imaging, and the tissue being treated. This clinical decision-making separates us from one-product clinics.
The ability to choose the right biologic source is a fundamental clinical advantage.
Patient Experience: Most patients value knowing we selected the best biologic for their specific condition rather than the only one available.
We are the only clinic in the Boulder area offering both BMA and MFAT with biologic selection based on pathology, combined with ultrasound-guided delivery and tissue priming through Dynamic Shockwave+.
Many clinics here focus primarily on spine and underserve patients with knee, hip, shoulder, ankle, and tendon conditions. Others rely on a single biologic or skip image guidance. Some use amniotic products containing no viable cells.
Our Dynamic Stem Cell+ protocol is built for patients with joint, tendon, and ligament conditions who want the highest quality care in this market.
If your issue is a knee, hip, shoulder, ankle, or tendon, you deserve a provider whose focus matches your needs.
Patient Experience: Patients who do their homework on clinics in this market consistently end up here because the clinical depth speaks for itself.
Yes. Professional athletes across every major sport use stem cell therapy for injury recovery, joint preservation, and career extension. The same biology works for you because the treatment uses your own cells.
Many professional football, baseball, basketball, and tennis players have used stem cells to return from injuries that might otherwise require surgery. The biological mechanisms are identical regardless of athletic level. What matters is biologic quality, injection accuracy, and rehabilitation protocol.
Our Dynamic Stem Cell+ protocol delivers the same caliber of regenerative treatment professional athletes receive, with the same precision and individualized care.
Your body responds to the same regenerative biology as a professional athlete’s body.
Patient Experience: Recreational athletes on the Front Range consistently report outcomes matching what they read about professional treatments.
Stem cell therapy has helped many patients return to skiing, hiking, cycling, and activities they thought were behind them by addressing the structural damage limiting their function.
Joint degeneration, tendon damage, and cartilage loss do not have to end your outdoor lifestyle. Stem cell therapy targets these structures at the cellular level, promoting repair and reducing the pain keeping you off the trails and slopes.
Our Dynamic Stem Cell+ protocol is built for active patients who refuse to accept their best days are behind them. We design return-to-sport protocols around your specific goals.
Your time on the mountain, the trails, and the roads matters. That is why we do this.
Patient Experience: Patients in their forties, fifties, and sixties are getting back to fourteeners, ski resorts, and trail running after treatment.
Yes. Stem cell therapy is safe for older adults because it uses your own cells, eliminating risks associated with donor tissue, synthetic drugs, and surgical procedures. Age alone is not a contraindication.
Older adults often have more advanced degeneration requiring higher-quality biologic preparation. While stem cell numbers in bone marrow decrease with age, the remaining cells are still functionally effective when properly concentrated and delivered.
Our Dynamic Stem Cell+ protocol adjusts preparation technique and delivery parameters based on patient age, condition severity, and tissue quality. We do not use the same prep approach for a 70-year-old as a 35-year-old.
Regenerative treatment is available at any age when performed appropriately.
Patient Experience: Many patients in their sixties and seventies respond well and maintain active lifestyles.
If stem cell therapy does not produce expected results, it does not eliminate your other options. Surgery, additional regenerative treatments, and other interventions remain available.
Stem cell therapy is conservative compared to surgery. It does not damage tissue, alter anatomy, or make surgery more difficult later. Some patients who proceed to surgery after stem cell therapy may heal faster because of the regenerative stimulus already delivered.
We set realistic expectations during evaluation and monitor progress after Dynamic Stem Cell+ treatment to determine whether additional treatment or a different approach is warranted.
Trying stem cells first preserves all of your options. Surgery only closes them.
Patient Experience: The majority of patients achieve meaningful improvement, but for those who need more, we always have a clear path forward.
Many clinics dismissed MFAT for years because they had invested in bone marrow as their only biologic, and acknowledging MFAT meant admitting their approach was incomplete.
The science supporting MFAT has been strong for over a decade. Adipose tissue contains dense regenerative cells within an intact extracellular matrix effective for tendon and soft tissue. Clinics that dismissed this have now adopted it as evidence became impossible to ignore.
We offered both BMA and MFAT from the beginning through our Dynamic Stem Cell+ protocol because evidence supported both. Our biologic selection has always been driven by pathology, not convenience.
Patients deserve a provider whose choices are driven by science, not by what was on the shelf.
Patient Experience: Many patients choose us specifically because we offer the biologic that fits their condition.
Yes. Stem cell therapy is often the next step for patients whose conditions improved with PRP but did not fully resolve, or conditions too advanced for PRP to address.
PRP provides concentrated growth factors. Stem cells deliver a broader range of regenerative cells with greater potency. For patients with more advanced degeneration or incomplete PRP response, stem cells can provide the additional biological stimulus needed.
We offer both Dynamic PRP+ and Dynamic Stem Cell+ as part of a stepwise regenerative approach. If PRP helped but was not enough, stem cells are a logical next step.
Having both biologics available means your treatment can escalate with your needs.
Patient Experience: Many patients who saw partial improvement with PRP achieve their full treatment goals after progressing to stem cells.
Stem cell therapy is not appropriate for active infections, certain cancers, uncontrolled bleeding disorders, or conditions where tissue damage is so severe that no biologic intervention can produce meaningful improvement.
Thorough medical history, physical examination, and imaging review are essential to determine candidacy. Not every patient is a candidate, and honest assessment is part of responsible regenerative medicine.
We evaluate every patient thoroughly before recommending Dynamic Stem Cell+ treatment. If you are not a good candidate, we will tell you directly and discuss alternatives. We would rather turn someone away than take their money for a treatment that won’t work.
Recommending treatment only when appropriate is how trust is built.
Patient Experience: Patients appreciate the honest evaluation process before any treatment is recommended.
Yes. Autologous stem cell therapy using your own BMA or MFAT is legal in Colorado and throughout the United States when performed as a same-day, minimally manipulated, homologous use procedure.
The FDA allows physicians to harvest, process, and reinject a patient’s own tissue in the same setting without it being classified as a drug. Devices used must be FDA-cleared.
Our Dynamic Stem Cell+ protocol strictly follows FDA guidelines for autologous point-of-care procedures. Unlike clinics operating in gray areas with unapproved products, we stay within the established regulatory framework.
Legitimate autologous stem cell therapy is well within the law.
Most patients feel reassured knowing their treatment at Dynamic Athlete operates within established regulatory guidelines.
Patient Experience: Next Steps: Review and approve content. Then HTML accordion + JSON-LD FAQPage schema will be produced.